Every Challenge Has a Backstory
America’s biopharmaceutical research companies are developing medicines, via biological processes, that tap into the body’s own immune system to treat more than 100 diseases. OBG partnered with a leading biopharmaceutical company on the comprehensive repurposing of an 80-acre former antibiotics manufacturing plant. The goal was to transform the site into a leading center for development of biologics manufacturing processes and manufacturing of biologics medicines for clinical trials and commercial use.
An Intricate, Simultaneous Decontamination and Demolition Program: An 80-year history of building at the site resulted in 118 buildings and the supporting infrastructure spread across a 20-acre campus. The decontamination and demolition of antibiotics manufacturing facilities, while simultaneously protecting ongoing biologics manufacturing, was a key challenge and priority for OBG.